Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v2.4.0.6
Debt (Tables)
 6 Months Ended
Mar. 31, 2012
Debt [Abstract]  
Interest Rate Swaps
The Company has entered into the following interest rate swaps:

Effective Date
Amount
Fixed Interest Rate
Interest Rate Spread at March 31, 2012
 
Maturity Date
September 2007
$25,000
4.77%
1.25%
September 2012
May 2008
  20,000
3.72%
1.25%
September 2012
May 2011
  25,000
1.37%
1.25%
May 2014
October 2011
  25,000
1.67%
1.25%
October 2015
November 2011
  25,000
2.13%
1.25%
November 2014
March 2012
  25,000
2.44%
1.25%
March 2015
September 2012
  25,000
3.03%
1.25%
December 2015
November 2012
  25,000
1.33%
1.25%
November 2015
Derivatives Designated as Hedging Instruments
At March 31, 2012 and September 30, 2011, the interest rate swap contracts were reflected as a liability on the balance sheets.  The following derivatives are designated as hedging instruments:

Liability Derivatives
Balance Sheet Location:
March 31, 2012
September 30, 2011
Current liabilities:
Other current liabilities
$ 2,616
$ 2,061
Long-term liabilities
Other liabilities
4,209
5,100
Total derivatives
$ 6,825
$ 7,161
Gain (Loss) Recognized on Derivatives
The loss recognized on derivatives was as follows:
Location of
Derivatives in
Loss
Amount of
Amount of
Cash Flow
Recognized in
Loss Recognized
Loss Recognized
Hedging
Income on
in Income
in Income
Relationships
Derivative
on Derivatives
on Derivatives
Three Months ended March 31,
Six Months ended March 31,
2012
2011
2012
2011
Interest rate swaps
Interest expense
$ (733)
$ (701)
$ (1,420)
$ (1,459)

The Company recognized the following losses in accumulated other comprehensive loss ("AOCL"):
Location of
Gain or
(Loss)
Amount of Loss
Reclassified
Reclassified from
Amount of
From
AOCL into
Derivatives in
Loss Recognized in
AOCL into
Income
Cash Flow
AOCL on Derivatives
Income
(Effective Portion*)
Hedging Relationships
March 31,
2012
March 31,
2011
(Effective
Portion*)
March 31, 2012
March 31,
2011
Interest rate swaps
$ (661)
$ (24)
Interest expense
$ (866)
$ (890)
*There is no ineffective portion or amount excluded from effectiveness testing.